HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF

The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.

Saved in:
Bibliographic Details
Main Authors RYU, Hee Sun, JUNG, Hong Ryul, JEON, Hyeon Ho, SON, Jung Beom, LEE, Young Yi, HWANG, Seon Ah, SHIM, In Seob, KIM, Sung Hwan, DO, Woo Mi, LEE, Youn Ho, KIM, Nam Doo
Format Patent
LanguageEnglish
Published 25.01.2024
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
Bibliography:Application Number: US202217927324